Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.

MLA

Yamayoshi, Seiya, et al. “Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 N Antibodies between December 2021 and March 2023 in Japan.” Epidemiology and Infection, vol. 152, Jan. 2024, p. e24. EBSCOhost, https://doi.org/10.1017/S0950268824000141.

APA

Yamayoshi, S., Nagai, E., Mitamura, K., Hagihara, M., Kobayashi, R., Takahashi, S., Shibata, A., Uwamino, Y., Hasegawa, N., Iqbal, A., Kamimaki, I., Iwatsuki-Horimoto, K., Nagamura-Inoue, T., & Kawaoka, Y. (2024). Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan. Epidemiology and Infection, 152, e24. https://doi.org/10.1017/S0950268824000141

Chicago

Yamayoshi, Seiya, Etsuko Nagai, Keiko Mitamura, Masao Hagihara, Ryo Kobayashi, Satoshi Takahashi, Akimichi Shibata, et al. 2024. “Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 N Antibodies between December 2021 and March 2023 in Japan.” Epidemiology and Infection 152 (January): e24. doi:10.1017/S0950268824000141.